EPISODE · Jan 18, 2022 · 8 MIN
SARS-CoV-2, Influenza A and B, and Respiratory Syncytial Virus (RSV) testing: Joseph Yao, M.D.
from Answers from the Lab · host Mayo Clinic Laboratories
(00:43):Before we get started, Dr. Yao, could you please provide our listeners with a little bit about you and your background? (01:24) Can you provide a brief overview and intended use of this testing? (02:34) Could you describe which patients should have this testing and when should it be performed? (05:07) Are there other options on the market? And if so, what makes our testing unique?(06:38) How are the test results used in patient care?
Embed this episode
What this episode covers
Joseph Yao, M.D., explains how Mayo Clinic Laboratories' four-target test for viral respiratory disease provides vital information for the treatment of at-risk patients. The PCR test detects RNA from SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus, or RSV. A standalone PCR test for RSV is also available.
NOW PLAYING
SARS-CoV-2, Influenza A and B, and Respiratory Syncytial Virus (RSV) testing: Joseph Yao, M.D.
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.